← SynDRA
QUINAPRILAT
SynDRA canonical compound SYN0019704 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | ACE |
|---|
| Mechanism of action | angiotensin converting enzyme inhibitor |
|---|
| Indication | angioedema | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- ACE inhibitor
- SLC33A1 INHIBITOR
Drug classes
- Angiotensin-converting Enzyme Inhibitors
- Angiotensin Converting Enzyme Inhibitor
- Antihypertensive Agents
- Cardiovascular Agents
- Enzyme Inhibitors
- Protease Inhibitors
ATC classes
- C09A · ACE INHIBITORS, PLAIN
- ACE INHIBITORS, COMBINATIONS
Cross-references
Synonyms
- Quinaprilate
- Quinapril diacid
- Quinapril related compound b
- CI-928
- NSC-759825
- NSC 759825
- quinapril related compound b (usp-rs)
- CI 928
- quinapril hydrochloride impurity c (ep impurity)
- quinapril related compound b
- quinapril related compound b (usp impurity)
- quinaprilate
- quinaprilatum
- CL-928
- CHEBI:140296
- RefChem:57156
- DTXCID30820879
- Quinapril EP Impurity C
- CI928
- A1I5A
- Quinapril diacid [MI]
- Quinaprilat [USAN:INN]
- UNII-34SSX5LDE5
- BRN 5653070
- MFCD08060097
- QUINAPRILAT [INN]
- Quinaprilat (USAN/INN)
- QUINAPRILAT [USAN]
- QUINAPRILAT [WHO-DD]
- SCHEMBL113237
- GTPL6352
- orb1705267
- SCHEMBL29598971
- FLSLEGPOVLMJMN-YSSFQJQWSA-N
- GLXC-15168
- HMS3264B04
- Pharmakon1600-01505455
- BDBM50367258
- NSC759825
Reported adverse events
- Cough
- Dizziness
- Fatigue
- Headache
- Nausea
- Vomiting
- Myalgia
- Hypotension
- Rash
- Alopecia
- Bradycardia
- Gastrointestinal carcinoma
Look up QUINAPRILAT in the interactive SynDRA portal →